Mesa Laboratories Inc.

06/16/2026 | Press release | Distributed by Public on 06/16/2026 14:48

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Crennen Lyndsey Elizabeth
2. Date of Event Requiring Statement (Month/Day/Year)
06/15/2026
3. Issuer Name and Ticker or Trading Symbol
MESA LABORATORIES INC /CO/ [MLAB]
(Last) (First) (Middle)
2850 S CLARKSON CIRCLE
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Accounting Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
ENGLEWOOD, CO 80113
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1,863 D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit - 1(3) 06/21/2026(1) (2) Common Stock 125 $0 D
Restricted Stock Unit - 2(3) 06/18/2026(4) (2) Common Stock 465 $0 D
Restricted Stock Units - 3(3) 06/19/2026(5) (2) Common Stock 735 $0 D
Restricted Stock Units(3) 06/13/2027(6) (2) Common Stock 542 $0 D
Restricted Stock Units - 5 03/02/2027(7) (2) Common Stock 1,800 $0 D
Restricted Stock Units 6(3) 06/15/2027(8) (2) Common Stock 1,443 $0 D
NSO -1 09/01/2022(9) 09/01/2027 Common Stock 369 $268.85 D
NSO - 2 06/15/2025(10) 06/15/2028 Common Stock 488 $185.57 D
NSO - 3 06/21/2024(11) 06/21/2029 Common Stock 646 $131.67 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Crennen Lyndsey Elizabeth
2850 S CLARKSON CIRCLE
ENGLEWOOD, CO 80113
Chief Accounting Officer

Signatures

John Sakys under Power of Attorney by Lyndsey Crennen 06/16/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Last tranche of the grant vests on June 21, 2026
(2) Not Applicable
(3) Each RSU represents a contingent right to receive one share of the Issuer's common stock
(4) RSUs that vest 233 shares on June 18, 2026 and 232 shares that vest on June 18, 2027
(5) RSUs that vest 368 shares on June 19, 2026 and 367 shares that vest on June 19, 2027
(6) RSUs that vest 271 shares on June 13, 2027 and 271 shares on June 13, 2028
(7) RSUs that vest 612 shares on March 2, 2027 and 594 shares that vest on each of March 2, 2028 and March 2, 2029
(8) RSUs that vest 34% on June 15, 2027, 33% on June 8, 2028 and 33% on June 8, 2029
(9) Non qualified stock options that were fully vested as of June 15, 2024
(10) Non qualified stock options that were fully vested as of June 15, 2025
(11) NSO's that will fully vest on June 21, 2026
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Mesa Laboratories Inc. published this content on June 16, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 16, 2026 at 20:48 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]